Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
12,498,551
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
10,343,866
-
Shares change
-
+391,054
-
Total reported value, excl. options
-
$155,080,846
-
Value change
-
+$6,727,909
-
Number of buys
-
27
-
Number of sells
-
10
-
Price
-
$15.00
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q3 2025
As of 30 Sep 2025 Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) had 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,343,866 shares of stock of the company.
Largest 10 holders included FRED ALGER MANAGEMENT, LLC, FEDERATED HERMES, INC., JANUS HENDERSON GROUP PLC, ORBIMED ADVISORS LLC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, VANGUARD GROUP INC, Cable Car Capital, LP, SPHERA FUNDS MANAGEMENT LTD., ADAGE CAPITAL PARTNERS GP, L.L.C., and Woodline Partners LP.
This table shows 42 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.